Nifty Pharma under pressure: Is it time to square off your positions?
A few Indian pharma companies are already working in the specialty products business in the US, which is a very high-value market as against…
23 November 2021
A few Indian pharma companies are already working in the specialty products business in the US, which is a very high-value market as against…
As the blustery pandemic pummeled mercilessly, the third-gender and Non-Binary community dis-proportionally condoned the socioeconomic hardships of the pandemic.
A collaborative consortium based approach with CDC as the touchbearer, can possibly reproduce better results in effective decision making to hault the diabolical virus.